This is a pooled fund: many plans invest in it, and it holds the underlying securities.
This filing is a Direct Filing Entity (DFE) — a master trust or collective investment trust that pools assets from multiple participating plans. It does not have plan participants of its own, and the Plan Health Score formula doesn’t apply. Individual participant-facing plans that invest in this trust are the appropriate target for fiduciary analysis.
Cited interest vs pooled assets: cited interest sums what each participating plan reported holding in this trust, measured at that plan’s own year-end — and those filings span different years. Pooled assets is this single filing’s balance at one date. They’re independent measurements, so cited interest can land slightly above or below the pooled balance and won’t reconcile exactly.
Why no Schedule of Assets here? DFE holdings often live on the master trust’s own audited statement, not as a 4i schedule on the participating plans’ filings. We’re extending the parsing pipeline to cover DFE filings — see Methodology.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $1.8M | — |
| KPMG LLP | 13-5565207 | — | NONE | $262K | — |
| MAPLES AND CALDER | — | — | NONE | $31K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $16K | — |
| KPMG AG FINANCIAL SERVICES | — | — | NONE | $10K | — |
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| TLV Partners II | — | — | $10.1M | $34.0M | 12.0% | |
| Polish Enterprises Fund VIII | — | — | $10.2M | $16.9M | 6.0% | |
| CX Partners Fund 2 | — | — | $9.7M | $15.3M | 5.4% | |
| G Square Capital III | — | — | $13.2M | $14.7M | 5.2% |
| GENUI Fund II GmbH & Co. KG | — | — | $9.3M | $13.5M | 4.8% |
| Nordic Capital IX | — | — | $8.7M | $12.7M | 4.5% |
| Astorg VII | — | — | $8.0M | $12.0M | 4.2% |
| Volcanics Venture Fund | — | — | $7.2M | $11.7M | 4.1% |
| BlackFin Financial Services Fund III | — | — | $10.8M | $11.1M | 3.9% |
| Source Code SFP Growth Fund | — | — | $8.8M | $10.9M | 3.9% |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Accel London VI | — | — | $6.8M | $9.8M | 3.5% |
| Waterland Private Equity Fund VII | — | — | $7.9M | $8.9M | 3.2% |
| HL Partners II | — | — | $4.5M | $8.4M | 3.0% |
| Zoo Capital Fund I | — | — | $6.7M | $7.9M | 2.8% |
| Quadrant Private Equity No. 6 | — | — | $6.9M | $6.6M | 2.3% |
| DBAG Fund VIII A | — | — | $6.2M | $6.4M | 2.3% |
| Affinity Asia Pacific Fund V | — | — | $5.2M | $6.3M | 2.2% |
| Mosaic Ventures II | — | — | $5.7M | $5.9M | 2.1% |
| Plemont Co-Investment No. 1 - Solix II | — | — | $7.6M | $5.7M | 2.0% |
| Timezone | — | — | $858K | $4.5M | 1.6% |
| Exact Software | — | — | $993K | $4.1M | 1.5% |
| Easy Park Holding AS | — | — | $723K | $3.9M | 1.4% |
| Redview Capital II | — | — | $4.3M | $3.5M | 1.2% |
| PSC Marlin | — | — | $1.3M | $3.3M | 1.2% |
| Symbiotec Pharmalab Private Limited | — | — | $947K | $3.3M | 1.2% |
| Independent Vetcare Limited | — | — | $398K | $2.7M | 1.0% |
| The Resolute II Continuation Fund LP | — | — | $1.2M | $2.4M | 0.8% |
| PDC Opportunities III B | — | — | $124K | $2.3M | 0.8% |
| Energy & Minerals Group Fund III | — | — | $3.8M | $2.2M | 0.8% |
| MYOB Group Limited | — | — | $1.5M | $2.0M | 0.7% |
| Aidite Technology Co., Ltd. | — | — | $627K | $1.6M | 0.6% |
| FS Equity Partners VII | — | — | $1.2M | $1.5M | 0.5% |
| India Business Excellence Fund IIA | — | — | $949K | $1.5M | 0.5% |
| DBAG Fund VIII B | — | — | $990K | $1.5M | 0.5% |
| TPG Asia VI | — | — | $1.4M | $1.4M | 0.5% |
| Oak HC/FT Partners | — | — | $891K | $1.3M | 0.5% |
| India Business Excellence Fund - IIIA | — | — | $471K | $1.2M | 0.4% |
| GI Partners IV | — | — | $1.4M | $1.2M | 0.4% |
| ZPG Plc | — | — | $1.6M | $1.2M | 0.4% |
| Blue Water Energy Fund I-A | — | — | $1.6M | $1.2M | 0.4% |
| Behrman Capital VI | — | — | $1.0M | $1.2M | 0.4% |
| Vivecti Group | — | — | $976K | $1.1M | 0.4% |
| FS Equity Partners VIII | — | — | $650K | $1.0M | 0.4% |
| TPG Fund Asia VII | — | — | $979K | $1.0M | 0.4% |
| Investindustrial IV Build up | — | — | $1.5M | $1.0M | 0.4% |
| World Gym Taiwan | — | — | $1.2M | $974K | 0.3% |
| Warburg Pincus XI | — | — | $2.3M | $895K | 0.3% |
| Adams Street 2017 Non-US Fund LP 2024 Form 5500, Schedule H FEIN 81-4057805, Plan Number 001 Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Millenna Capital | — | — | $693K | $807K | 0.3% |
| Leqee Group Limited | — | — | $784K | $762K | 0.3% |
| CIVC Partners Fund V | — | — | $401K | $750K | 0.3% |
| BC European Capital X | — | — | $534K | $730K | 0.3% |
| PSC III G, LP | — | — | $177K | $654K | 0.2% |
| JPMorgan US Government Money Market Fund | — | — | $643K | $643K | 0.2% |
| Accel London II | — | — | $164K | $470K | 0.2% |
| Leqee Group Limited II | — | — | $570K | $466K | 0.2% |
| ACP Investment Fund | — | — | $3.5M | $357K | 0.1% |
| Capital Economics Research Ltd | — | — | $218K | $332K | 0.1% |
| Capital Economics Research Ltd | — | — | $178K | $330K | 0.1% |
| Lauderdale GmbH | — | — | $412K | $304K | 0.1% |
| Phoenix Equity Partners 2016 Fund | — | — | $234K | $273K | <0.1% |
| TA Associates XI 0 | — | — | — | $267K | <0.1% |
| PDC Opportunities VII A | — | — | $84K | $267K | <0.1% |
| ACP Investment Fund II | — | — | $440K | $247K | <0.1% |
| Gaosi Education Group | — | — | $894K | $222K | <0.1% |
| Prairie V 0 | — | — | — | $209K | <0.1% |
| FTV IV 0 | — | — | — | $163K | <0.1% |
| Energy & Minerals Group Fund II | — | — | $170K | $161K | <0.1% |
| SK Capital Partners V | — | — | $138K | $157K | <0.1% |
| SK Capital IV-A | — | — | $148K | $140K | <0.1% |
| Industrial Opportunity II | — | — | $2.1M | $117K | <0.1% |
| DTCP Venture Fund II Parallel GmbH & Co. KG | — | — | $102K | $105K | <0.1% |
| Welsh, Carson, Anderson & Stowe XII | — | — | $74K | $75K | <0.1% |
| SK Capital Partners III | — | — | $156K | $72K | <0.1% |
| TPG Asia V | — | — | $125K | $67K | <0.1% |
| Madison Dearborn Capital Partners VI | — | — | — | $61K | <0.1% |
| CIVC Partners Fund IV | — | — | $959K | $59K | <0.1% |
| FTVentures III | — | — | $71K | $46K | <0.1% |
| Mankind Pharma Ltd. | — | — | — | $28K | <0.1% |
| TPG Partners VI | — | — | $433K | $18K | <0.1% |
| Capital Economics Research Ltd | — | — | $8K | $12K | <0.1% |
| Accel Europe | — | — | $55K | $11K | <0.1% |
| Schülerhilfe 0 | — | — | — | $9K | <0.1% |
| Welsh, Carson, Anderson & Stowe XI | — | — | $709K | $5K | <0.1% |
| Career Partners GmbH 0 | — | — | — | $3K | <0.1% |
